These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6382303)

  • 1. Hypocholesterolemia in myeloproliferative diseases with myelofibrosis.
    Ginsberg H; Gilbert HS
    Prog Clin Biol Res; 1984; 154():345-57. PubMed ID: 6382303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid metabolism disorders in patients with retinal artery occlusions].
    Fellinger C; Schmut O; Hofmann H
    Klin Monbl Augenheilkd; 1984 Feb; 184(2):109-11. PubMed ID: 6716886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.
    Gilbert HS; Ginsberg H; Fagerstrom R; Brown WV
    Am J Med; 1981 Oct; 71(4):595-602. PubMed ID: 7282748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of plasma levels of apolipoprotein E and of HDL-cholesterol in gouty patients].
    Frati E; Castagna ML; Bacarelli M; Giordano N; Fioravanti A; Pucci G; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1063-9. PubMed ID: 6590073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
    Viikari J; Solakivi-Jaakkola T; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased low-density-lipoprotein catabolism in myeloproliferative disorders.
    Ginsberg H; Gilbert HS; Gibson JC; Le NA; Brown WV
    Ann Intern Med; 1982 Mar; 96(3):311-6. PubMed ID: 7059093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma apolipoproteins A-I, A-II, and B, and lipoprotein cholesterol after jejunoileal bypass.
    Goldberg RB; Weinberg RB; Landau RL
    Gastroenterology; 1983 Apr; 84(4):732-6. PubMed ID: 6402411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the importance of new test of HDL-cholesterol in lipoid diagnostics with geriatric patients (author's transl)].
    Braun M
    Aktuelle Gerontol; 1982 Mar; 12(2):50-3. PubMed ID: 6123271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in plasma high density lipoprotein cholesterol with weight loss.
    Ruggiero M; Brunese M; Morelli S; Mangoni C; Stefano S
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):798-804. PubMed ID: 7272052
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides.
    Kjeldsen SE; Eide I; Leren P; Foss OP
    Scand J Clin Lab Invest; 1983 Apr; 43(2):119-21. PubMed ID: 6577578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vascular hydrostatic pressure on the plasma concentrations of HDL-cholesterol, LDL-cholesterol and triglycerides in healthy subjects].
    Rodríguez Portillo M; Fabiani Romero F; Trujillo Rodríguez F
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):111-4. PubMed ID: 7313202
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
    Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein profile following food intake].
    Mertz DP; Göhmann E; Oelze R; Bürvenich K
    MMW Munch Med Wochenschr; 1982 Feb; 124(5):98-100. PubMed ID: 6806640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.